US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic
Undated handout picture of a Bavarian Nordic research team member holding a test tube obtained by Reuters on August 16, 2024. Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F Kennedy Jr, a vaccine sceptic, as health secretary, the company’s CEO said on Friday. Shares…